In T2DM, GLP-1RAs are generally recommended as a second-line therapy after metformin, along with other drug classes, such as sodium-glucose co-transporter 2 (SGLT2) and dipeptidyl peptidase-4 (DPP-4) inhibitors [36]. Here, DPP4 is linked to type 2 diabetes mellitus.